# Tenofovir vs. Tenofovir Plus Entecavir in Entecavir-Resistant Chronic Hepatitis B

> **NCT01639092** · PHASE4 · COMPLETED · sponsor: **Asan Medical Center** · enrollment: 88 (actual)

## Conditions studied

- Chronic Viral Hepatitis B Without Delta-agent

## Interventions

- **DRUG:** Tenofovir
- **DRUG:** Tenofovir
- **DRUG:** Entecavir

## Key facts

- **NCT ID:** NCT01639092
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09-28
- **Primary completion:** 2018-03-29
- **Final completion:** 2018-03-29
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2018-05-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01639092

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01639092, "Tenofovir vs. Tenofovir Plus Entecavir in Entecavir-Resistant Chronic Hepatitis B". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01639092. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*